Connection

Hossein Khalili to Drug Combinations

This is a "connection" page, showing publications Hossein Khalili has written about Drug Combinations.
Connection Strength

0.222
  1. Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed. 2020 11 10; 91(4):e2020102.
    View in: PubMed
    Score: 0.106
  2. Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia. J Comp Eff Res. 2018 09; 7(9):901-911.
    View in: PubMed
    Score: 0.091
  3. A Randomized Clinical Trial of the Efficacy and Safety of Interferon ß-1a in Treatment of Severe COVID-19. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.